Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Thursday, May 3, 2012
Raising Awareness of Hepatitis B In the Asian and Pacific Islander Communities
Viral Hepatitis Disparities in the Asian American and Pacific Islander Communities
Liver cancer and other liver problems caused by viral hepatitis (for example, cirrhosis) affect some U.S. populations more than others, resulting in substantial health disparities. This is especially true for Asian and Pacific Islanders Americans (APIs). In fact, an estimated 1 in 12 APIs are living with chronic hepatitis B. So, although Asian/Pacific Islander Americans make up only some 5 percent of the total U.S. population, they represent 50 percent of the estimated 800,000—1.4 million persons who are infected with hepatitis B in the United States. These health disparities are further reflected in viral hepatitis–associated illness and death. For example, liver cancer incidence is highest among the API population. Despite these high rates, many APIs are not tested for hepatitis B, thus remaining unaware of their infection and not accessing lifesaving medical care and appropriate treatment. Read more about this health disparity and what can be done at CDC’s Viral Hepatitis and APIs page.